Visual Impairment and Frailty: Examining an Understudied Relationship.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
14 02 2020
Historique:
received: 30 03 2019
pubmed: 17 8 2019
medline: 21 11 2020
entrez: 17 8 2019
Statut: ppublish

Résumé

Older adults with visual impairments are at increased risk of negative health outcomes. Here, we investigate the association between visual impairment and frailty. Cross-sectional and longitudinal relationships between visual impairment (distance visual acuity) and frailty (frailty phenotype criteria) were examined using data from the National Health and Nutrition Examination Survey (NHANES, 1999-2002, ≥60 years) and the Women's Health and Aging Studies (WHAS III). Imbalance of potential confounders, particularly age, was addressed using propensity score-based adjustment. Multinomial logistic regression determined the odds of prefrailty and frailty at baseline in NHANES and ordinal logistic regression examined the odds of baseline and incident frailty over 3 years in WHAS III after adjustment for confounders and probability weighting (survey weights × inverse propensity scores). In NHANES (n = 2,639, 9% vision impairment), participants with visual impairment were more likely to be prefrail (odds ratio [OR] = 3.2; 95% confidence interval [CI]: 1.9-5.3) and frail (OR = 3.7; 95% CI: 1.5-9.2) than those without visual impairment. In WHAS III (n = 796, 26% mild, 37% moderate/severe vision impairment), participants with mild and moderate/severe vision impairment were more likely to be frail (OR = 2.0; 95% CI: 1.5-2.5; OR = 5.5; 95% CI: 4.2-7.2, respectively). A one-line worse visual acuity (0.1 logMAR increase) was associated with greater odds of frailty (OR = 1.5; 95% CI: 1.4-1.7). Of those non-frail at baseline (n = 549), moderate/severe visual impairment and one-line worse visual acuity was associated with greater odds of incident frailty (OR = 3.5; 95% CI: 1.4-8.4; OR = 1.3; 95% CI: 1.1-1.5, respectively) over 3 years. Visual impairment may be an important, yet understudied risk factor for frailty.

Sections du résumé

BACKGROUND
Older adults with visual impairments are at increased risk of negative health outcomes. Here, we investigate the association between visual impairment and frailty.
METHODS
Cross-sectional and longitudinal relationships between visual impairment (distance visual acuity) and frailty (frailty phenotype criteria) were examined using data from the National Health and Nutrition Examination Survey (NHANES, 1999-2002, ≥60 years) and the Women's Health and Aging Studies (WHAS III). Imbalance of potential confounders, particularly age, was addressed using propensity score-based adjustment. Multinomial logistic regression determined the odds of prefrailty and frailty at baseline in NHANES and ordinal logistic regression examined the odds of baseline and incident frailty over 3 years in WHAS III after adjustment for confounders and probability weighting (survey weights × inverse propensity scores).
RESULTS
In NHANES (n = 2,639, 9% vision impairment), participants with visual impairment were more likely to be prefrail (odds ratio [OR] = 3.2; 95% confidence interval [CI]: 1.9-5.3) and frail (OR = 3.7; 95% CI: 1.5-9.2) than those without visual impairment. In WHAS III (n = 796, 26% mild, 37% moderate/severe vision impairment), participants with mild and moderate/severe vision impairment were more likely to be frail (OR = 2.0; 95% CI: 1.5-2.5; OR = 5.5; 95% CI: 4.2-7.2, respectively). A one-line worse visual acuity (0.1 logMAR increase) was associated with greater odds of frailty (OR = 1.5; 95% CI: 1.4-1.7). Of those non-frail at baseline (n = 549), moderate/severe visual impairment and one-line worse visual acuity was associated with greater odds of incident frailty (OR = 3.5; 95% CI: 1.4-8.4; OR = 1.3; 95% CI: 1.1-1.5, respectively) over 3 years.
CONCLUSIONS
Visual impairment may be an important, yet understudied risk factor for frailty.

Identifiants

pubmed: 31419280
pii: 5550824
doi: 10.1093/gerona/glz182
pmc: PMC7328203
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

596-602

Subventions

Organisme : NIA NIH HHS
ID : P30 AG021334
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG052640
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

JAMA Ophthalmol. 2014 Dec;132(12):1400-6
pubmed: 25144579
Am J Med. 2009 Jul;122(7):664-71.e2
pubmed: 19559169
Trans Am Ophthalmol Soc. 2003;101:191-6; discussion 196-9
pubmed: 14971577
Health Serv Res. 2014 Feb;49(1):284-303
pubmed: 23855598
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):262-6
pubmed: 16567375
Ophthalmology. 2012 Jan;119(1):106-11
pubmed: 21962256
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Gerontol A Biol Sci Med Sci. 2000 Jan;55(1):M43-52
pubmed: 10719772
Am J Epidemiol. 2014 Feb 1;179(3):313-22
pubmed: 24148711
Invest Ophthalmol Vis Sci. 2013 Jan 07;54(1):193-200
pubmed: 23221066
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Arch Gerontol Geriatr. 2015 May-Jun;60(3):464-70
pubmed: 25697060
Ophthalmology. 2002 Jul;109(7):1235-42
pubmed: 12093644
J Clin Epidemiol. 1994 Jul;47(7):747-60
pubmed: 7722588
J Am Geriatr Soc. 2017 Jan;65(1):179-184
pubmed: 27861714
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
pubmed: 15031310
J Am Med Dir Assoc. 2014 Sep;15(9):635-42
pubmed: 24746590
J Aging Health. 2019 May 8;:898264319847818
pubmed: 31068051
J Am Geriatr Soc. 2015 Jan;63(1):46-54
pubmed: 25536849
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
J Epidemiol Community Health. 2017 Nov;71(11):1053-1058
pubmed: 28798152
Invest Ophthalmol Vis Sci. 2013 Jan 28;54(1):799-803
pubmed: 23307956
Invest Ophthalmol Vis Sci. 2013 Nov 19;54(12):7683-90
pubmed: 24176902
Ophthalmology. 2012 Dec;119(12):2486-92
pubmed: 22892152
Am J Ophthalmol. 1982 Jul;94(1):91-6
pubmed: 7091289

Auteurs

Bonnielin K Swenor (BK)

Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Moon J Lee (MJ)

Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Jing Tian (J)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Varshini Varadaraj (V)

Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Karen Bandeen-Roche (K)

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH